Comparison of primary and secondary enucleation for uveal melanoma

References

• Singh AD, Turell ME, Topham AK. Uveal melanoma: trends in incidence, treatment, and survival. Ophthalmology 2011; 118(9):1881–1885.
   PubMed Web of Science ®Google Scholar
• Collaborative Ocular Melanoma Study Group. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report No. 28. Arch Ophthalmol 2006; 124(12):1684–1693.
   PubMedGoogle Scholar
• Diener-West M, Earle JD, Fine SL, et al. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: III. Initial mortality findings. COMS Report No. 18. Arch Ophthalmol 2001; 119(7):969–982.
   PubMedGoogle Scholar
• Muller RP, Busse H, Potter R, et al. Results of high dose 106-ruthenium irradiation of choroidal melanomas. Int J Radiat Oncol Biol Phys 1986; 12:1749–55.
   PubMed Web of Science ®Google Scholar
• Bergman L, Nilsson B, Lundell G, et al. Ruthenium brachytherapy for uveal melanoma, 1979–2003: survival and functional outcomes in the Swedish population. Ophthalmology 2005; 112:834–40
   PubMed Web of Science ®Google Scholar
• Georgopoulos M, Zehetmayer M, Ruhswurm I, et al. Tumour regression of uveal melanoma after ruthenium-106 brachytherapy or stereotactic radiotherapy with gamma knife or linear accelerator. Ophthalmologica 2003; 217:315–319.
   PubMed Web of Science ®Google Scholar
• Sikuade MJ, Salvi S, Rundle PA, Errington DG, et al. Outcomes of treatment with stereotactic radiosurgery or proton beam therapy for choroidal melanoma. Eye (Lond) 2015; 29(9):1194–1198.
   PubMed Web of Science ®Google Scholar
• Peyman GA, Juarez CT, Diamond JG, et al. (1984) Ten years’ experience with eyewall resection for uveal malignant melanomas. Ophthalmology 1984; 91(12):1720–1725.
   PubMed Web of Science ®Google Scholar
• Char DH, Miller T, Crawford JB. Uveal tumour resection. Br J Ophthal 2001; 85(10):1213–1219.
   PubMed Web of Science ®Google Scholar
• Vail DT. Iridocyclectomy, A review. Am J Ophthalmol 1971; 71:161–168.
   PubMed Web of Science ®Google Scholar
• Wen JC, Oliver SC, McCannel TA. Ocular complications following I-125 brachytherapy for choroidal melanoma. Eye 2009; 23:1254–1268.
   PubMed Web of Science ®Google Scholar
• Sagoo MS, Shields CL, Emrich J, et al. Plaque radiotherapy for juxtapapillary choroidal melanoma: treatment complications and visual outcomes in 650 consecutive cases. JAMA Ophthalmol 2014; 132(6):697–702.
   PubMed Web of Science ®Google Scholar
• Connolly G, Wladis E, Masselam K, Weinberg DA. Contralateral orbital melanoma 28 years following enucleation for choroidal melanoma. Orbit 2007;26(4):291–294.
   PubMedGoogle Scholar
• Shields JA, Augsburger JJ, Donoso LA, et al. Hepatic metastasis and orbital recurrence of uveal melanoma after 42 years. Am J Ophthalmol 1985; 100(5):666–668.
   PubMed Web of Science ®Google Scholar
• Shields JA, Augsburger JJ, Dougherty MJ. Orbital recurrence of choroidal melanoma 20 years after enucleation. Am J Ophthalmol 1984; 97(6):767–770.
   PubMed Web of Science ®Google Scholar
• Chang MY, McCannel TA. Local treatment failure after globe-conserving therapy for choroidal melanoma. Br J Ophthalmol 2013;97:804–811.
   PubMed Web of Science ®Google Scholar
• Collaborative Ocular Melanoma Study Group: Collaborative Ocular Melanoma Study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma: I. Visual acuity after 3 years. COMS Report No. 16. Ophthalmology 2001; 108(2):348–366.
   Google Scholar
• Shields CL, Shields JA, Karlsson U, et al. Enucleation after plaque radiotherapy for posterior uveal melanoma. Ophthalmology 1990; 97(12):1665–1670.
   PubMed Web of Science ®Google Scholar
• Collaborative Ocular Melanoma Study Group: The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS Report No. 19. Ophthalmology 2002; 198:2197–2206.
   Google Scholar
• Gündüz K, Shields CL, Shields JA, et al. Radiation complications and tumor control after plaque radiotherapy of choroidal melanoma with macular involvement. Am J Ophthalmol 1999; 127(5):579–589.
   PubMed Web of Science ®Google Scholar
• Shields CL, Shields JA, Karlsson U, et al. Reasons for enucleation after plaque radiotherapy for posterior uveal melanoma: clinical findings. Ophthalmology 1989; 96(6):919–923.
   PubMed Web of Science ®Google Scholar
• Bartamian M, Meyer DR. Site of service, anesthesia, and postoperative practice patterns for oculoplastic and orbital surgeries. Ophthalmology 1996;103:1628–1633.
   PubMed Web of Science ®Google Scholar
• Badrinath SS, Bhaskaran S, Sundararaj I, et al. Mortality and morbidity associated with ophthalmic surgery. Ophthalm Surg Lasers 1995; 26(6):535–541.
   PubMedGoogle Scholar
• Sinclair DR, Chung F, Mezei G. Can postoperative nausea and vomiting be predicted? Anesthesiology 1999; 91(1):109–118.
   PubMed Web of Science ®Google Scholar
• Fisher BW, Majumdar SR, McAlister FA. Predicting pulmonary complications after nonthoracic surgery: a systematic review of blinded studies. Am J Med 2002; 112(3):219–225.
   PubMed Web of Science ®Google Scholar
• Wong DH, Weber EC, Schell MJ, et al. Factors associated with postoperative pulmonary complications in patients with severe chronic obstructive pulmonary disease. Anesth Analg 1995; 80(2):276–284.
   PubMed Web of Science ®Google Scholar
• Fabian ID, Tomkins-Netzer O, Stoker I, et al. Secondary enucleations for uveal melanoma: A 7-year retrospective analysis. Am J Ophthalmol 2015; 160(6):1104–1110.
   PubMed Web of Science ®Google Scholar
• Smith B, Bosniak S, Nesi F, Lisman R. Dermis-fat orbital implantation: 118 cases. Ophthalmic Surg 1983; 14:941–943.
   PubMedGoogle Scholar
• Jovanovic P, Mihajlovic M, Djordjevic-Jocic J, et al. Ocular Melanoma: an overview of the current status. Int J Clin Exp Pathol 2013; 6(7):1230–1244.
   PubMed Web of Science ®Google Scholar
• Shields CL, Furuta M, Thangappan A, et al. Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes. Arch Ophthalmol 2009; 127: 989–998.
   PubMedGoogle Scholar
• Onken MD, Worley LA, Ehlers JP, Harbour JW. Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res 2004; 64:7205–7209.
   PubMed Web of Science ®Google Scholar
• Aaberg TM Jr, Cook RW, Oelschlager K, et al. Current clinical practice: differential management of uveal melanoma in the era of molecular tumor analyses. Clin Ophthalmol 2014; 8:2449–2460.
   PubMedGoogle Scholar